Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
, 33621493, 33087936, 30566856, 39947938; doi: https://doi.org/10.1101/2025.03.15.641049 ). Postdoctoral Projects Project 1: Replisome Dynamics, Replication Stress, and Cancer Vulnerabilities This project aims
-
maintaining transgenic mouse lines including blood collection, ear tagging, and tail clipping. Experience in laboratory management, such as ordering supplies, preparing reagents, and maintain lab organization
-
. To evaluate the impact of these MPs on thyroid function using the regulatory XETA assay (TG 248), developed and mastered in the laboratory, on transgenic lines. An additional study on neuronal and
-
maintaining transgenic mouse lines including blood collection, ear tagging, and tail clipping. Experience in laboratory management, such as ordering supplies, preparing reagents, and maintain lab organization
-
conducting electrophysiological, histological and behavioural research in transgenic model animals at the Department of Physiology IP PAS. Department Head: Professor Krzysztof Tokarski, PhD KEYWORDS
-
on chronobiology and neuroscience related research projects. Manage transgenic and knockout mouse colonies, pup weaning and genotyping. Maintain adequate inventory of laboratory supplies; order and organize
-
senior members of the team. What you would be doing Work will involve a combination of innovative techniques including genetic library-based screening, imaging and dedicated transgenic model organism work
-
imaging, human tissue organoids, CAR-T cells, CRISPR–Cas9–guided gene or epigenetic editing, and inducible transgenic models targeting dendritic cells, tissue-resident macrophages, the tissue niche, and
-
requests from researchers, plant care, cleaning, and routine maintenance. Conduct lab data collection as well as field trials measurements in conjunction with associated researchers. Dispose of transgenic
-
(IDH1/2) genes and this project focusses on how these mutations re-program liver cells, in the context of biliary cancer. We are using CRISPR-edited human cells and novel transgenic models in mice